SF
DGX icon

Synovus Financial’s Quest Diagnostics DGX Stock Holding History

Synovus Financial’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-70,100
Closed -$3.75M – 944
2013
Q4 		$3.75M Buy
+70,100
New +$4.16M 0.11% 118

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Synovus Financial's DGX Position: Q4 2023 in Review

Synovus Financial sold out of Quest Diagnostics (DGX) in Q4 2023, closing a stake of 2,079 shares — an estimated $253K sold.

Synovus Financial first reported a position in DGX in Q2 2013 and held it in 29 quarters. The position peaked at $490K in Q4 2021. 827 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

  • Synovus Financial reported no remaining Quest Diagnostics position as of Q4 2023 after selling out during the quarter.
  • Synovus Financial sold 2,079 Quest Diagnostics shares in Q4 2023, an estimated $253K.
  • Synovus Financial first reported a position in Quest Diagnostics in Q2 2013 and held it in 29 quarters.
  • Synovus Financial's Quest Diagnostics position peaked at $490K in Q4 2021.
  • 827 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on Synovus Financial's 13F filing for Q4 2023, filed 14 Feb 2024.